Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
EG.1.1SWon-SCTACATGCACCAGCAACTGT20502311423133F-22142.8South Korea
XAFSWon-SCTACATGCACCAGCAACTGT20502311423133F-22142.8South Korea
BC.2SWon-SCTACATGCACCAGCAACTGT20502311423133F-2729.83South Korea
P.1.17.1 (Gamma)SWon-SCTACATGCACCAGCAACTGT20502311423133F-22142.8South Korea
BA.2.3.16SWon-SCTACATGCACCAGCAACTGT20502311423133F-22142.8South Korea
B.1.177.41SWon-SCTACATGCACCAGCAACTGT20502311423133F-22142.8South Korea
B.1.1.375SWon-SCTACATGCACCAGCAACTGT20502311423133F-22142.8South Korea
BL.1.4SWon-SCTACATGCACCAGCAACTGT20502311423133F-22142.8South Korea
B.1.626SWon-SCTACATGCACCAGCAACTGT20502311423133F-22142.8South Korea
B.1.629SWon-SCTACATGCACCAGCAACTGT20502311423133F-22142.8South Korea
GA.9SWon-SCTACATGCACCAGCAACTGT20502311423133F-22142.8South Korea
AY.61 (Delta)SWon-SCTACATGCACCAGCAACTGT20502311423133F-22142.8South Korea
BA.2.75.6SWon-SCTACATGCACCAGCAACTGT20502311423133F-22142.8South Korea
GC.2SWon-SCTACATGCACCAGCAACTGT20502311423133F-22142.8South Korea
BQ.1.1.16SWon-SCTACATGCACCAGCAACTGT20502311423133F-22142.8South Korea
B.1.1.524SWon-SCTACATGCACCAGCAACTGT20502311423133F-22142.8South Korea
BA.5.2.38SWon-SCTACATGCACCAGCAACTGT20502311423133F-22142.8South Korea
BA.1.15.3SWon-SCTACATGCACCAGCAACTGT20502311423133F-22142.8South Korea
B.1.1.15SWon-SCTACATGCACCAGCAACTGT20502311423133F-22142.8South Korea
AY.59 (Delta)SWon-SCTACATGCACCAGCAACTGT20502311423133F-22142.8South Korea
XBRSWon-SCTACATGCACCAGCAACTGT20502311423133F-22142.8South Korea
DJ.1.1.1SWon-SCTACATGCACCAGCAACTGT20502311423133F-22142.8South Korea
CH.1.1.21SWon-SCTACATGCACCAGCAACTGT20502311423133F-22142.8South Korea
AZ.5SWon-SCTACATGCACCAGCAACTGT20502311423133F-22142.8South Korea
B.1.1.193SWon-SCTACATGCACCAGCAACTGT20502311423133F-22142.8South Korea
BL.4SWon-SCTACATGCACCAGCAACTGT20502311423133F-22142.8South Korea
FP.3SWon-SCTACATGCACCAGCAACTGT20502311423133F-22142.8South Korea
DA.1SWon-SCTACATGCACCAGCAACTGT20502311423133F-22142.8South Korea
AY.68 (Delta)SWon-SCTACATGCACCAGCAACTGT20502311423133F-22142.8South Korea
BQ.1.1.14SWon-SCTACATGCACCAGCAACTGT20502311423133F-22142.8South Korea
BA.1.16.1SWon-SCTACATGCACCAGCAACTGT20502311423133F-22142.8South Korea
DN.1.1.1SWon-SCTACATGCACCAGCAACTGT20502311423133F-22142.8South Korea
B.1.160.28SWon-SCTACATGCACCAGCAACTGT20502311423133F-22142.8South Korea
AY.5.2 (Delta)SWon-SCTACATGCACCAGCAACTGT20502311423133F-22142.8South Korea
DN.1.1.4SWon-SCTACATGCACCAGCAACTGT20502311423133F-22142.8South Korea
BA.1.4SWon-SCTACATGCACCAGCAACTGT20502311423133F-22142.8South Korea
AY.84 (Delta)SWon-SCTACATGCACCAGCAACTGT20502311423133F-22142.8South Korea
BA.2.60SWon-SCTACATGCACCAGCAACTGT20502311423133F-22142.8South Korea
BA.2.9.2SWon-SCTACATGCACCAGCAACTGT20502311423133F-22142.8South Korea
BA.2.11SWon-SCTACATGCACCAGCAACTGT20502311423133F-22142.8South Korea
BA.2.3.15SWon-SCTACATGCACCAGCAACTGT20502311423133F-22142.8South Korea
BA.5.6.1SWon-SCTACATGCACCAGCAACTGT20502311423133F-22142.8South Korea
BA.5.1.35SWon-SCTACATGCACCAGCAACTGT20502311423133F-22142.8South Korea
XBB.1.45SWon-SCTACATGCACCAGCAACTGT20502311423133F-22142.8South Korea
B.1.177.31SWon-SCTACATGCACCAGCAACTGT20502311423133F-22142.8South Korea
B.1.160.26SWon-SCTACATGCACCAGCAACTGT20502311423133F-22142.8South Korea
AY.39.1.2 (Delta)SWon-SCTACATGCACCAGCAACTGT20502311423133F-22142.8South Korea
AY.4.15 (Delta)SWon-SCTACATGCACCAGCAACTGT20502311423133F-22142.8South Korea
BA.2.75.10SWon-SCTACATGCACCAGCAACTGT20502311423133F-22142.8South Korea
B.1.36.21SWon-SCTACATGCACCAGCAACTGT20502311423133F-22142.8South Korea
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used